Research Use Only. Not for human therapeutic use. All data cited from peer-reviewed preclinical literature.
TB-500 is a synthetic peptide derived from the actin-sequestering protein Thymosin Beta-4 (Tβ4), the most abundant intracellular G-actin sequestering protein in most mammalian cells. Tβ4’s primary molecular function — binding monomeric G-actin through its LKKTET actin-binding domain — positions it as a master regulator of actin dynamics, cytoskeletal remodelling, cell migration, and wound repair. The eye represents one of the most intensively studied applications of Tβ4/TB-500 biology: corneal epithelial repair, corneal wound healing, lacrimal gland restoration, retinal ganglion cell neuroprotection, and aqueous humour dynamics for intraocular pressure research have all been investigated in preclinical ocular models. This post surveys the ocular research biology of TB-500/Tβ4 across corneal, retinal, and anterior segment contexts.
🔗 Related Reading: For a comprehensive overview of TB-500 research, mechanisms, UK sourcing, and safety data, see our TB-500 UK Complete Research Guide 2026.
Corneal Epithelial Repair: Actin Dynamics and Cell Migration Biology
The corneal epithelium — a stratified non-keratinising squamous epithelium 5–7 cell layers thick — maintains the primary refractive surface of the eye and the first physical barrier against infection. Corneal epithelial wound healing proceeds through: (1) immediate actin cytoskeletal reorganisation at wound edges; (2) epithelial cell migration across the denuded stroma (leading edge lamellipodia and filopodia formation); (3) mitotic proliferation of basal epithelial cells and limbal stem cells restoring cell number; and (4) differentiation and stratification to restore barrier function. Tβ4’s actin-sequestering activity directly regulates steps 1 and 2: by releasing G-actin monomers for barbed-end polymerisation at the leading edge, Tβ4 promotes lamellipodial actin network formation and directional cell migration.
Tβ4/TB-500 corneal epithelial research employs multiple wound models. The alkali burn model (NaOH 0.1–1 N applied to the corneal surface via filter paper disc, 10–60 s exposure) produces reproducible epithelial and stromal damage, with healing assessed by fluorescein staining under cobalt blue illumination (fluorescein defect area by image analysis). The n-heptanol debridement model (6 mm filter paper disc soaked in n-heptanol applied 1 min — dissolves basolateral membranes, detaching epithelium without stromal injury) produces a pure epithelial defect ideal for studying migration without confounding stromal inflammation. Surgical epithelial debridement (diamond burr or Alger brush) produces more reproducible uniform defects for pharmacokinetic and dose-response studies.
Corneal wound healing endpoints: fluorescein-stained defect area at 0, 6, 12, 18, 24, 48, 72 h (digital photography under standardised illumination); healing rate (mm²/h); time to complete re-epithelialisation; and confocal microscopy (HRT-II confocal, in vivo corneal confocal microscopy — IVCM) of epithelial wing cell density, basal cell density, and sub-basal nerve plexus density (corneal nerve fibre length, density, branching). Histology at wound closure: PAS staining for goblet cells, K3/K12 keratin IHC (corneal epithelial differentiation), Ki-67 IHC (limbal stem cell proliferative activity), and ZO-1/claudin-1/E-cadherin IHC (barrier junction restoration). Scratch assay (in vitro, human corneal epithelial cells HCE-T or primary HCECs) with timelapse microscopy quantifies the direct migration-promoting effect of Tβ4/TB-500 at defined concentrations.
Corneal Stroma and Keratocyte Biology
The corneal stroma — composed of collagen lamellae (primarily Col1/Col5) and keratocytes (corneal stromal fibroblasts) — provides mechanical strength and optical clarity through highly ordered collagen fibril organisation. Stromal wounding activates keratocytes to proliferating fibroblasts, then (if repair is incomplete) to myofibroblasts (α-SMA-positive, contractile, collagen-producing) that can produce disorganised scar tissue disrupting optical clarity — the primary complication of post-refractive surgery haze.
